4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-21-030141
Chief Operating Officer sold 14,500 shares at an average $37.84 ($548,656)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nabulsi Azmi Chief Operating Officer | 2021-05-03 | Sale | −4,290 | $37.85 | $162,360 | 775,910 | I |
| Nabulsi Azmi Chief Operating Officer | 2021-05-03 | Sale | −5,753 | $38.59 | $221,994 | 770,157 | I |
| Nabulsi Azmi Chief Operating Officer | 2021-05-04 | Sale | −1,968 | $36.15 | $71,150 | 768,189 | I |
| Nabulsi Azmi Chief Operating Officer | 2021-05-04 | Sale | −1,400 | $37.09 | $51,921 | 766,789 | I |
| Nabulsi Azmi Chief Operating Officer | 2021-05-04 | Sale | −1,089 | $37.86 | $41,231 | 765,700 | I |
| Open-market sales · 14,500 sh · avg $37.84 · $548,656 | |||||||
Loading xslF345X03/doc4.xml…